Colistin as A Good Monotherapy to Restrain the Pathogenicity of Acinetobacter baumannii In vivo and In vitro. Baghdad Science Journal, Iraq, Baghdad, v. 19, n. 2, p. 0255, 2022. DOI: 10.21123/bsj.2022.19.2.0255. Disponível em: https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/5706.. Acesso em: 2 may. 2024.